Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Biofabrication of gene activated grafts targeting synovial joint inflammation and meniscus repair

Obiettivo

Each year an estimated 1.5 million meniscal repair surgeries are performed in the United States and Europe, making this one of the most common procedures in orthopaedics. Current clinical management involves partial or total removal of the damaged tissue, increasing osteoarthritis (OA) risk 14-fold. Conventional meniscal tissue engineering strategies have failed to recapitulate the structure, composition and cellular complexity of the native meniscus, limiting clinical translation. Moreover, they rarely address the inflammatory synovial microenvironment accompanying meniscal lesions, a key factor that impedes healing and accelerates OA progression. SMART-MENISCUS aims to develop the first genetically modified, zonally defined meniscal graft that recapitulates the complexity of the native meniscus while actively targeting synovial inflammation. The project is structured into three interconnected aims addressing the biological complexity and translational challenges of meniscus regeneration. Aim 1 will test whether human mesenchymal stem cell-derived microtissues can be 3D bioprinted into melt-electrowritten (MEW) scaffolds to generate anisotropic grafts with defined collagen architecture and load-bearing capacity and evaluate their resistance to inflammatory degradation under dynamic loading. Aim 2 will focus on the development of gene-activated constructs by integrating microRNA-loaded nanoparticles in the MEW scaffolds to control gene expression, drive regeneration and modulate post-injury inflammation. Finally, Aim 3 will engineer autologous, gene-activated, scaled-up meniscus grafts and validate their regenerative efficacy and immunomodulatory potential in a large animal model. SMART-MENISCUS will improve recovery after meniscus injuries, reduce OA risk, and minimize the need for costly medical interventions. This project will enhance functional meniscus regeneration and the quality of life for millions affected by meniscal damage and synovial joint degeneration.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2026-STG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Contributo netto dell'UE
€ 1 375 000,00
Indirizzo
COLLEGE GREEN TRINITY COLLEGE
D02 CX56 Dublin
Irlanda
Regione
Ireland Eastern and Midland Dublin
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 375 000,00

Beneficiari (2)